[HTML][HTML] Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
KR Talaat, C Alaimo, P Martin, AL Bourgeois… - …, 2021 - thelancet.com
Background Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
KR Talaat, C Alaimo, P Martin, AL Bourgeois… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
KR Talaat, C Alaimo, P Martin, AL Bourgeois… - …, 2021 - pure.johnshopkins.edu
Background: Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection.
KR Talaat, C Alaimo, P Martin, AL Bourgeois… - Ebiomedicine, 2021 - europepmc.org
Background Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
[HTML][HTML] Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
KR Talaat, C Alaimo, P Martin, AL Bourgeois… - …, 2021 - ncbi.nlm.nih.gov
Background Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
[HTML][HTML] Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
KR Talaat, C Alaimo, P Martin, AL Bourgeois… - eBioMedicine, 2021 - Elsevier
Background Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …